Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track CRL with free AI briefings, catalyst countdowns, and dilution alerts.

CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$192M Cash on Hand

CF+ Cash Runway

Follow CRL by email Get an email when CRL pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about CRL, unsubscribe in one click. Privacy

🧪 Trial & FDA Catalysts

Nov 2026 · N/A · Recruiting · LA Function After PFA in Paroxysmal AF
Registry primary completion date, not a results date
Dec 2026 · N/A · Recruiting · Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and
Registry primary completion date, not a results date
Dec 2026 · N/A · Recruiting · Evaluation of SaCoVLM™ Video Laryngeal Mask for Airway Management in Military Medics
Registry primary completion date, not a results date
Dec 2026 · N/A · Recruiting · FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patien
Registry primary completion date, not a results date
Dec 2026 · N/A · Upcoming Trial · IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer
Registry primary completion date, not a results date
Dec 2026 · N/A · Upcoming Trial · Comprehensive Therapeutic Program For People With Multiple Sclerosis
Registry primary completion date, not a results date

📊 Drug Pipeline

Drug	Indication	Most advanced trial	Status
Psilocybine	Depression	Phase 2 · NCT06512194	Recruiting
Molnupiravir	COVID-19	N/A · NCT07720596	Completed

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

CRL holds $192M in cash and short-term investments (as of Jun 27, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

No operating cash burn in latest filings

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CRL files for a raise →

Get the full CRL picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CRL and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z